Citation tools
"Targeting, Toxicity, and Efficacy of 2-Step, Pretargeted Radioimmunotherapy Using a Chimeric Bispecific Antibody and 131I-Labeled Bivalent Hapten in a Phase I Optimization Clinical Trial." Journal of Nuclear Medicine
47.2
(2006):
247-255.
Web. 25 April. 2025.